Fatigue in advanced kidney disease

Fatigue is commonly experienced in patients with advanced kidney disease and associated with poor outcomes. The prevalence of fatigue ranges from 42% to as high as 89% according to treatment modality and the measurement instruments used. This paper reviews studies examining sociodemographic, biologi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Kidney international 2014-09, Vol.86 (3), p.497-505
Hauptverfasser: Artom, Micol, Moss-Morris, Rona, Caskey, Fergus, Chilcot, Joseph
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 505
container_issue 3
container_start_page 497
container_title Kidney international
container_volume 86
creator Artom, Micol
Moss-Morris, Rona
Caskey, Fergus
Chilcot, Joseph
description Fatigue is commonly experienced in patients with advanced kidney disease and associated with poor outcomes. The prevalence of fatigue ranges from 42% to as high as 89% according to treatment modality and the measurement instruments used. This paper reviews studies examining sociodemographic, biological, and psychological factors associated with fatigue in advanced kidney disease. The association between fatigue and psychological factors, such as depression and anxiety, behavioral factors, such as sleep and nutrition, and cytokines, such as IL-6 and CRP corroborates the view of fatigue as a multidimensional and multifactorial problem. Although depression and fatigue are related, the relationship is typically moderate in size, thus fatigue should not simply be seen as a symptom of distress. Accordingly, it is important for treatment plans to address the complex etiology of fatigue through pharmacological and nonpharmacological interventions. To date, results of nonpharmacological interventions are promising, with physical exercise and cognitive-behavioral therapy showing beneficial results. Work conducted in other patient populations highlights the importance of cognitions and behaviors in the prediction and maintenance of fatigue. Such work could be applied to advanced kidney disease allowing a model of fatigue to be developed from which to base suitable interventions in this setting.
doi_str_mv 10.1038/ki.2014.86
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1558516862</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0085253815303318</els_id><sourcerecordid>1558516862</sourcerecordid><originalsourceid>FETCH-LOGICAL-c466t-8f56d093455d42920477308428c0265e57f48277746ed818f7e1259f0f986c853</originalsourceid><addsrcrecordid>eNpt0E9LwzAYx_EgipvTiy9Ail5E6HyS5knSowynwsCLnkNNnkr2p51NO9i7t3PqQTyFwIcfD1_GzjmMOWTmdhHGArgcG3XAhhxFlnKNeMiGAAZTgZkZsJMY59D_8wyO2UBIlcvc4JBdTos2vHeUhCop_KaoHPlkEXxF28SHSEWkU3ZUFstIZ9_viL1O718mj-ns-eFpcjdLnVSqTU2JykOeSUQvRS5Aap2BkcI4EAoJdSmN0FpLRd5wU2riAvMSytwoZzAbsev97rqpPzqKrV2F6Gi5LCqqu2g5okGujBI9vfpD53XXVP11Xwo0gIJe3eyVa-oYGyrtugmrotlaDnZXzi6C3ZWzRvX44nuye1uR_6U_qXog94D6BptAjY0u0K5XaMi11tfhv91PcDh12A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1558070060</pqid></control><display><type>article</type><title>Fatigue in advanced kidney disease</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>ProQuest Central UK/Ireland</source><source>Alma/SFX Local Collection</source><creator>Artom, Micol ; Moss-Morris, Rona ; Caskey, Fergus ; Chilcot, Joseph</creator><creatorcontrib>Artom, Micol ; Moss-Morris, Rona ; Caskey, Fergus ; Chilcot, Joseph</creatorcontrib><description>Fatigue is commonly experienced in patients with advanced kidney disease and associated with poor outcomes. The prevalence of fatigue ranges from 42% to as high as 89% according to treatment modality and the measurement instruments used. This paper reviews studies examining sociodemographic, biological, and psychological factors associated with fatigue in advanced kidney disease. The association between fatigue and psychological factors, such as depression and anxiety, behavioral factors, such as sleep and nutrition, and cytokines, such as IL-6 and CRP corroborates the view of fatigue as a multidimensional and multifactorial problem. Although depression and fatigue are related, the relationship is typically moderate in size, thus fatigue should not simply be seen as a symptom of distress. Accordingly, it is important for treatment plans to address the complex etiology of fatigue through pharmacological and nonpharmacological interventions. To date, results of nonpharmacological interventions are promising, with physical exercise and cognitive-behavioral therapy showing beneficial results. Work conducted in other patient populations highlights the importance of cognitions and behaviors in the prediction and maintenance of fatigue. Such work could be applied to advanced kidney disease allowing a model of fatigue to be developed from which to base suitable interventions in this setting.</description><identifier>ISSN: 0085-2538</identifier><identifier>EISSN: 1523-1755</identifier><identifier>DOI: 10.1038/ki.2014.86</identifier><identifier>PMID: 24694985</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Age Factors ; chronic kidney disease ; Comorbidity ; Cytokines - blood ; Depression - psychology ; end-stage renal disease ; fatigue ; Fatigue - blood ; Fatigue - epidemiology ; Fatigue - etiology ; Fatigue - psychology ; Fatigue - therapy ; Humans ; Renal Insufficiency, Chronic - complications ; Renal Insufficiency, Chronic - therapy ; Severity of Illness Index ; Sex Factors ; symptoms ; transplantation ; treatment</subject><ispartof>Kidney international, 2014-09, Vol.86 (3), p.497-505</ispartof><rights>2014 International Society of Nephrology</rights><rights>Copyright Nature Publishing Group Sep 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c466t-8f56d093455d42920477308428c0265e57f48277746ed818f7e1259f0f986c853</citedby><cites>FETCH-LOGICAL-c466t-8f56d093455d42920477308428c0265e57f48277746ed818f7e1259f0f986c853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1558070060?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24694985$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Artom, Micol</creatorcontrib><creatorcontrib>Moss-Morris, Rona</creatorcontrib><creatorcontrib>Caskey, Fergus</creatorcontrib><creatorcontrib>Chilcot, Joseph</creatorcontrib><title>Fatigue in advanced kidney disease</title><title>Kidney international</title><addtitle>Kidney Int</addtitle><description>Fatigue is commonly experienced in patients with advanced kidney disease and associated with poor outcomes. The prevalence of fatigue ranges from 42% to as high as 89% according to treatment modality and the measurement instruments used. This paper reviews studies examining sociodemographic, biological, and psychological factors associated with fatigue in advanced kidney disease. The association between fatigue and psychological factors, such as depression and anxiety, behavioral factors, such as sleep and nutrition, and cytokines, such as IL-6 and CRP corroborates the view of fatigue as a multidimensional and multifactorial problem. Although depression and fatigue are related, the relationship is typically moderate in size, thus fatigue should not simply be seen as a symptom of distress. Accordingly, it is important for treatment plans to address the complex etiology of fatigue through pharmacological and nonpharmacological interventions. To date, results of nonpharmacological interventions are promising, with physical exercise and cognitive-behavioral therapy showing beneficial results. Work conducted in other patient populations highlights the importance of cognitions and behaviors in the prediction and maintenance of fatigue. Such work could be applied to advanced kidney disease allowing a model of fatigue to be developed from which to base suitable interventions in this setting.</description><subject>Age Factors</subject><subject>chronic kidney disease</subject><subject>Comorbidity</subject><subject>Cytokines - blood</subject><subject>Depression - psychology</subject><subject>end-stage renal disease</subject><subject>fatigue</subject><subject>Fatigue - blood</subject><subject>Fatigue - epidemiology</subject><subject>Fatigue - etiology</subject><subject>Fatigue - psychology</subject><subject>Fatigue - therapy</subject><subject>Humans</subject><subject>Renal Insufficiency, Chronic - complications</subject><subject>Renal Insufficiency, Chronic - therapy</subject><subject>Severity of Illness Index</subject><subject>Sex Factors</subject><subject>symptoms</subject><subject>transplantation</subject><subject>treatment</subject><issn>0085-2538</issn><issn>1523-1755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpt0E9LwzAYx_EgipvTiy9Ail5E6HyS5knSowynwsCLnkNNnkr2p51NO9i7t3PqQTyFwIcfD1_GzjmMOWTmdhHGArgcG3XAhhxFlnKNeMiGAAZTgZkZsJMY59D_8wyO2UBIlcvc4JBdTos2vHeUhCop_KaoHPlkEXxF28SHSEWkU3ZUFstIZ9_viL1O718mj-ns-eFpcjdLnVSqTU2JykOeSUQvRS5Aap2BkcI4EAoJdSmN0FpLRd5wU2riAvMSytwoZzAbsev97rqpPzqKrV2F6Gi5LCqqu2g5okGujBI9vfpD53XXVP11Xwo0gIJe3eyVa-oYGyrtugmrotlaDnZXzi6C3ZWzRvX44nuye1uR_6U_qXog94D6BptAjY0u0K5XaMi11tfhv91PcDh12A</recordid><startdate>20140901</startdate><enddate>20140901</enddate><creator>Artom, Micol</creator><creator>Moss-Morris, Rona</creator><creator>Caskey, Fergus</creator><creator>Chilcot, Joseph</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20140901</creationdate><title>Fatigue in advanced kidney disease</title><author>Artom, Micol ; Moss-Morris, Rona ; Caskey, Fergus ; Chilcot, Joseph</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c466t-8f56d093455d42920477308428c0265e57f48277746ed818f7e1259f0f986c853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Age Factors</topic><topic>chronic kidney disease</topic><topic>Comorbidity</topic><topic>Cytokines - blood</topic><topic>Depression - psychology</topic><topic>end-stage renal disease</topic><topic>fatigue</topic><topic>Fatigue - blood</topic><topic>Fatigue - epidemiology</topic><topic>Fatigue - etiology</topic><topic>Fatigue - psychology</topic><topic>Fatigue - therapy</topic><topic>Humans</topic><topic>Renal Insufficiency, Chronic - complications</topic><topic>Renal Insufficiency, Chronic - therapy</topic><topic>Severity of Illness Index</topic><topic>Sex Factors</topic><topic>symptoms</topic><topic>transplantation</topic><topic>treatment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Artom, Micol</creatorcontrib><creatorcontrib>Moss-Morris, Rona</creatorcontrib><creatorcontrib>Caskey, Fergus</creatorcontrib><creatorcontrib>Chilcot, Joseph</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Kidney international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Artom, Micol</au><au>Moss-Morris, Rona</au><au>Caskey, Fergus</au><au>Chilcot, Joseph</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fatigue in advanced kidney disease</atitle><jtitle>Kidney international</jtitle><addtitle>Kidney Int</addtitle><date>2014-09-01</date><risdate>2014</risdate><volume>86</volume><issue>3</issue><spage>497</spage><epage>505</epage><pages>497-505</pages><issn>0085-2538</issn><eissn>1523-1755</eissn><abstract>Fatigue is commonly experienced in patients with advanced kidney disease and associated with poor outcomes. The prevalence of fatigue ranges from 42% to as high as 89% according to treatment modality and the measurement instruments used. This paper reviews studies examining sociodemographic, biological, and psychological factors associated with fatigue in advanced kidney disease. The association between fatigue and psychological factors, such as depression and anxiety, behavioral factors, such as sleep and nutrition, and cytokines, such as IL-6 and CRP corroborates the view of fatigue as a multidimensional and multifactorial problem. Although depression and fatigue are related, the relationship is typically moderate in size, thus fatigue should not simply be seen as a symptom of distress. Accordingly, it is important for treatment plans to address the complex etiology of fatigue through pharmacological and nonpharmacological interventions. To date, results of nonpharmacological interventions are promising, with physical exercise and cognitive-behavioral therapy showing beneficial results. Work conducted in other patient populations highlights the importance of cognitions and behaviors in the prediction and maintenance of fatigue. Such work could be applied to advanced kidney disease allowing a model of fatigue to be developed from which to base suitable interventions in this setting.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>24694985</pmid><doi>10.1038/ki.2014.86</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0085-2538
ispartof Kidney international, 2014-09, Vol.86 (3), p.497-505
issn 0085-2538
1523-1755
language eng
recordid cdi_proquest_miscellaneous_1558516862
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; ProQuest Central UK/Ireland; Alma/SFX Local Collection
subjects Age Factors
chronic kidney disease
Comorbidity
Cytokines - blood
Depression - psychology
end-stage renal disease
fatigue
Fatigue - blood
Fatigue - epidemiology
Fatigue - etiology
Fatigue - psychology
Fatigue - therapy
Humans
Renal Insufficiency, Chronic - complications
Renal Insufficiency, Chronic - therapy
Severity of Illness Index
Sex Factors
symptoms
transplantation
treatment
title Fatigue in advanced kidney disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T16%3A00%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fatigue%20in%20advanced%20kidney%20disease&rft.jtitle=Kidney%20international&rft.au=Artom,%20Micol&rft.date=2014-09-01&rft.volume=86&rft.issue=3&rft.spage=497&rft.epage=505&rft.pages=497-505&rft.issn=0085-2538&rft.eissn=1523-1755&rft_id=info:doi/10.1038/ki.2014.86&rft_dat=%3Cproquest_cross%3E1558516862%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1558070060&rft_id=info:pmid/24694985&rft_els_id=S0085253815303318&rfr_iscdi=true